Hello and welcome to the details of Six EU states voice ‘severe concern’ over Pfizer vaccine delays and now with the details
VILNIUS (Lithuania), Jan 15 — Six European Union countries signed a letter to the European Commission today to express “severe concern” over delivery delays for the coronavirus vaccine developed by BioNTech and Pfizer.
Ministers from Denmark, Estonia, Finland, Latvia, Lithuania and Sweden said in their letter that the situation was “unacceptable” and “decreases the credibility of the vaccination process”.
“We are obliged to inform our public and the particular risk groups... that their vaccination will be delayed, regardless of the outstanding efforts by our governments to ensure timely delivery,” the letter said.
“We request you to urgently engage with BioNTech/Pfizer to demand a public explanation of the situation and to stress the need to ensure stability and transparency of timely deliveries.”
It said officials in the six countries had been informed by BioNTech/Pfizer that deliveries would be “substantially reduced in the coming weeks”.
“Some were given the deadline of February 8, 2021, some were given no information on the duration of the intended decreased deliveries,” it added.
Lithuania earlier today said that deliveries of the vaccine would be cut to 54,505 doses from the originally planned 108,810 doses over the next four weeks — a reduction of nearly 50 per cent. — AFP
These were the details of the news Six EU states voice ‘severe concern’ over Pfizer vaccine delays for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.